Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net income (loss) $ (114,311) $ (27,264)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 11,692 10,724
Amortization of debt issuance costs and discount 857 608
Equity-based compensation expense 11,326 8,658
(Gain) loss on sale of joint ventures (1,303) 0
(Gain) loss on change in fair value of committed equity facility 0 255
(Gain) loss on change in fair value of warrants 51,960 2,011
Deferred provision (benefit) for income taxes (1,803) (925)
Income from equity method investments 0 (245)
Non-cash lease expense 227 327
Non-cash interest expense 0 525
Other 2,050 (238)
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable 14,670 (5,562)
(Increase) decrease in contract assets (7,138) (5,442)
(Increase) decrease in inventory (734) (44)
(Increase) decrease in prepaid insurance 108 1,157
(Increase) decrease in prepaid expenses and other assets (1,901) (928)
Increase (decrease) in accounts payable and accrued expenses 4,365 (3,280)
Increase (decrease) in deferred revenue 3,207 22,736
Increase (decrease) in operating lease liabilities (342) (325)
Increase (decrease) in other liabilities 9,722 (960)
Increase (decrease) in notes payable to sellers 0 (557)
Net cash provided by (used in) operating activities (17,348) 1,231
Cash flows from investing activities:    
Acquisition of businesses, net of cash acquired (881) 0
Net proceeds from sale of joint ventures 4,598 0
Purchases of property, plant and equipment (6,399) (5,620)
Purchase of intangible assets (4,517) (2,707)
Net cash provided by (used in) investing activities (7,199) (8,327)
Cash flows from financing activities:    
Proceeds received from debt 45,971 36,696
Repayments of debt (8,863) (26,683)
Payment of debt issuance fees to third parties (780) (163)
Repayment of finance leases (479) (395)
Proceeds from third-party advances 7,820 0
Proceeds from issuance of common stock 2,669 1,241
Payment of committed equity facility transaction costs 0 (571)
Payments of issuance costs related to convertible preferred stock 0 (52)
Shares repurchased for settlement of employee tax withholdings on share-based awards (2,622) (570)
Payment of contingent earnout 0 (443)
Net cash provided by (used in) financing activities 43,716 9,060
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash (376) (2)
Net increase (decrease) in cash, cash equivalents and restricted cash 18,793 1,962
Cash, cash equivalents and restricted cash at beginning of period 30,278 28,316
Cash, cash equivalents and restricted cash at end of period $ 49,071 $ 30,278